Traws Pharma (TRAW) Tops Q1 EPS by 209c
Get Alerts TRAW Hot Sheet
Join SI Premium – FREE
Traws Pharma (NASDAQ: TRAW) reported Q1 EPS of $2.09. Revenue for the quarter came in at $60 thousand.
For earnings history and earnings-related data on Traws Pharma (TRAW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Traws Pharma (TRAW) Tops Q2 EPS by 27c
- Zentek files patent for graphene EMI shielding coating from Albany graphite
- QumulusAI reports preliminary Q2 2026 financials
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share